Exendin (5-39) is a potent Glukagon-like peptide 1 ( GLP-1 ) receptor antagonist. Exendin (5-39) improves memory impairment in β-amyloid protein-treated rats
In Vivo
Exendin (5-39) (intracerebroventricular injection; 0.3 μg; once daily; 1-week) increases GLT-1 protein levels in the hippocampus of male Wistar rats. Additionally, hippocampal slices are prepared from Ex-treated or vehicle rats,Exendin (5-39) decreases fEPSP decay time and increases the input-output relation and decreased the paired-pulse ratio in the dentate gyrus (DG). Furthermore, Ex inhibits long-term depression but not long-term potentiation in the DG . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Wistar rats (3 weeks old and 18 days pregnant) Dosage: 0.3 μg Administration: Intracerebroventricular injection; 0.3 μg; once daily; 1-week Result: Inhibited GLT-1 protein levels and inhibited long-term depression in rats.
Form:Solid
IC50& Target:IC50: GLP-1 receptor
사양
사양 및 순도
≥99%
생화학 및 생리적 메커니즘
Exendin (5-39) is a potent Glukagon-like peptide 1 ( GLP-1 ) receptor antagonist. Exendin (5-39) improves memory impairment in β-amyloid protein-treated rats.
보관 조건
Protected from light,Argon charged,Desiccated,Store at -80°C
배송
Dry ice packs + Cold packs
이 제품은 콜드 체인 배송이 필요합니다.지상 및 기타 경제 서비스는 사용할 수 없습니다.
작업 유형
ANTAGONIST
순수함
≥99%
이름과 식별자
분자량
3806.30
고급 데이터
인증서(CoA, COO, BSE/TSE 및 분석 차트)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
솔루션 계산기
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.